Humanwell Healthcare Group Co Ltd (600079) - Total Assets
Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) holds total assets worth CN¥37.19 Billion CNY (≈ $5.44 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Humanwell Healthcare Group Co Ltd - Total Assets Trend (1994–2025)
This chart illustrates how Humanwell Healthcare Group Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Humanwell Healthcare Group Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Humanwell Healthcare Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Humanwell Healthcare Group Co Ltd's total assets of CN¥37.19 Billion consist of 55.7% current assets and 44.3% non-current assets. Review 600079 liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 11.3% |
| Accounts Receivable | CN¥9.40 Billion | 25.6% |
| Inventory | CN¥3.33 Billion | 9.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥2.65 Billion | 7.2% |
| Goodwill | CN¥355.67 Million | 1.0% |
Asset Composition Trend (1994–2025)
This chart illustrates how Humanwell Healthcare Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Humanwell Healthcare Group Co Ltd (600079) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Humanwell Healthcare Group Co Ltd's current assets represent 55.7% of total assets in 2025, an increase from 53.2% in 1994.
- Cash Position: Cash and equivalents constituted 11.3% of total assets in 2025, up from 2.1% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 3.0% in 1994.
- Asset Diversification: The largest asset category is accounts receivable at 25.6% of total assets.
Humanwell Healthcare Group Co Ltd Competitors by Total Assets
Key competitors of Humanwell Healthcare Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
|
India | Rs443.12 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Beijing Tongrentang Co Ltd
SHG:600085
|
China | CN¥29.95 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664
|
China | CN¥14.08 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
Humanwell Healthcare Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 1.54 | 1.29 |
| Quick Ratio | 1.63 | 1.29 | 1.08 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥10.30 Billion | CN¥7.28 Billion | CN¥3.95 Billion |
Humanwell Healthcare Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Humanwell Healthcare Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.55 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 0.6% |
| Total Assets | CN¥36.75 Billion |
| Market Capitalization | $4.47 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Humanwell Healthcare Group Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Humanwell Healthcare Group Co Ltd's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Humanwell Healthcare Group Co Ltd (1994–2025)
The table below shows the annual total assets of Humanwell Healthcare Group Co Ltd from 1994 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥36.75 Billion ≈ $5.38 Billion |
+0.65% |
| 2024-12-31 | CN¥36.51 Billion ≈ $5.34 Billion |
+0.84% |
| 2023-12-31 | CN¥36.20 Billion ≈ $5.30 Billion |
+0.50% |
| 2022-12-31 | CN¥36.02 Billion ≈ $5.27 Billion |
+1.74% |
| 2021-12-31 | CN¥35.41 Billion ≈ $5.18 Billion |
+9.20% |
| 2020-12-31 | CN¥32.42 Billion ≈ $4.74 Billion |
-10.07% |
| 2019-12-31 | CN¥36.05 Billion ≈ $5.28 Billion |
-0.35% |
| 2018-12-31 | CN¥36.18 Billion ≈ $5.29 Billion |
-0.25% |
| 2017-12-31 | CN¥36.27 Billion ≈ $5.31 Billion |
+37.25% |
| 2016-12-31 | CN¥26.43 Billion ≈ $3.87 Billion |
+45.59% |
| 2015-12-31 | CN¥18.15 Billion ≈ $2.66 Billion |
+49.19% |
| 2014-12-31 | CN¥12.17 Billion ≈ $1.78 Billion |
+25.34% |
| 2013-12-31 | CN¥9.71 Billion ≈ $1.42 Billion |
+23.48% |
| 2012-12-31 | CN¥7.86 Billion ≈ $1.15 Billion |
+27.40% |
| 2011-12-31 | CN¥6.17 Billion ≈ $902.92 Million |
+45.93% |
| 2010-12-31 | CN¥4.23 Billion ≈ $618.73 Million |
+27.82% |
| 2009-12-31 | CN¥3.31 Billion ≈ $484.07 Million |
+29.51% |
| 2008-12-31 | CN¥2.55 Billion ≈ $373.77 Million |
+5.67% |
| 2007-12-31 | CN¥2.42 Billion ≈ $353.70 Million |
+5.05% |
| 2006-12-31 | CN¥2.30 Billion ≈ $336.68 Million |
+12.51% |
| 2005-12-31 | CN¥2.04 Billion ≈ $299.24 Million |
+12.06% |
| 2004-12-31 | CN¥1.82 Billion ≈ $267.02 Million |
+8.22% |
| 2003-12-31 | CN¥1.69 Billion ≈ $246.75 Million |
+18.17% |
| 2002-12-31 | CN¥1.43 Billion ≈ $208.81 Million |
+43.96% |
| 2001-12-31 | CN¥991.27 Million ≈ $145.05 Million |
+91.32% |
| 2000-12-31 | CN¥518.12 Million ≈ $75.82 Million |
+9.91% |
| 1999-12-31 | CN¥471.41 Million ≈ $68.98 Million |
+30.95% |
| 1998-12-31 | CN¥359.98 Million ≈ $52.68 Million |
+34.75% |
| 1997-12-31 | CN¥267.15 Million ≈ $39.09 Million |
+85.45% |
| 1996-12-31 | CN¥144.06 Million ≈ $21.08 Million |
+32.35% |
| 1995-12-31 | CN¥108.85 Million ≈ $15.93 Million |
+11.71% |
| 1994-12-31 | CN¥97.44 Million ≈ $14.26 Million |
-- |
About Humanwell Healthcare Group Co Ltd
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more